Quantifying exploratory low dose compounds in humans with AMS

Stephen R Dueker1, Le T Vuong, Peter N Lohstroh

  • 1Vitalea Science, Inc, Davis, CA 95618, USA. stephen.dueker@vitaleascience.com

Summary

Accelerator Mass Spectrometry (AMS) offers attomole sensitivity, enabling low-dose radioisotope studies in diverse populations. This technology provides crucial insights into human physiochemistry for toxicological, nutritional, and pharmacological research.